Application

17725237 · DRUG COMBINATION TREATMENTS USING BONE-TARGETING THERAPEUTICS FOR BONE AND BONE-RELATED DISEASE

Filed 2022-04-20 · Abandoned The official file ↗ · Art unit 1618 · Examiner James William Rogers Typical · CPC A61P 19/08 · MBC Pharma · FisherBroyles, LLP - CW General

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

35.0 mo

to disposition 42.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.